ALS Investment Fund Overview
ALS Investment Fund is a venture capital firm that supports and finances biotech companies developing drugs and diagnostics for neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS). Initiated by three Dutch ALS patients and advised by Life Sciences Partners, the fund invests globally, focusing on Europe and the US, leveraging deep disease-specific knowledge and an extensive network in the field.
Is ALS Investment Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with ALS Investment Fund, along with a list of other relevant VCs, is available on Hopohopo.io.
ALS Investment Fund
Investment focus
Product type
- Drugs / Pharma
- Other
Industries / verticals
- BioTech & Life Sciences
- PharmaTech
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€3,000,000 - €50,000,000
Contact information
Managing Partner
Craig Boyce
Managing Director
Rist Brouwer
Managing Partner
Felix Coerper
Co-Founder BOX
Nancy Ruiter
Chief Executive Officer and Chief Scientific Officer
Fernando Vieira
How to approach funds like ALS Investment Fund
When approaching ALS Investment Fund, founders should highlight the scientific rigor and translational potential of their neurodegenerative disease programs, especially those with clear clinical milestones and a path to patient impact. Demonstrating strong connections to leading academic or clinical partners and a credible plan for regulatory and reimbursement pathways will resonate. The fund values teams with deep domain expertise and a collaborative mindset, given their active engagement with the ALS research and patient community.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
